表紙:臨床検査室サービスの世界市場 (第6版)
市場調査レポート
商品コード
1010064

臨床検査室サービスの世界市場 (第6版)

Clinical Laboratory Services Market, 6th Edition

出版日: | 発行: Kalorama Information | ページ情報: 英文 240 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.41円
臨床検査室サービスの世界市場 (第6版)
出版日: 2021年06月08日
発行: Kalorama Information
ページ情報: 英文 240 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の臨床検査室サービスの市場について分析し、市場の定義や基本構造、各国の医療制度や背景事情、全体的な市場規模の実績値 (2010年~2019年) と予測値 (2020年~2025年)、専門領域別・検査室の種類別・地域別/主要国の詳細動向、主要企業のプロファイル、将来の成長機会と課題などを調査しております。

目次

第1章 エグゼクティブサマリー

第2章 業界の概要

  • 臨床検査室の概要
  • 検査室に勤務する医療従事者の人数:国別
    • 米国:世界最大の臨床検査市場
  • 関連規制
  • 支払者と医療費償還
  • 価格設定の透明性
  • DTC (DIRECT-TO-CONSUMER) テスト
    • 遺伝子検査におけるDTC
  • がん検査の利用拡大と技術
  • 情報技術の役割
  • 業界の促進要因
    • 世界の人口構造
      • 地域別の人口:概要
      • 高齢化人口
    • 慢性疾患と症状
    • 景気動向
      • 医療費

第3章 検査サービス市場:専門領域別

  • 検査・サービス:概要
  • 臨床化学:日常検査・必須検査
    • 日常臨床化学的検査 (生化学検査)
    • コレステロールレベル検査
    • 尿検査
    • 血液検査
      • 血球数
    • 凝固検査
    • 内分泌検査
      • 甲状腺機能検査
      • 妊娠検査
  • 免疫・微生物学的検査
    • アレルギー・食物不耐性検査
    • 腫瘍マーカー検査
    • 心臓マーカー検査
    • HIV検査
  • 細胞診・組織検査
    • パップテスト
  • 遺伝子検査
  • 毒性試験
  • COVID-19ウイルス検査

第4章 世界の臨床検査市場:プロバイダーのグループ別

  • 臨床検査市場:プロバイダーの概要
  • 病院・救急医療プロバイダー
  • 医師・外来ケアプロバイダー
    • 開業医
    • 介護施設・介護付き老人ホーム
    • 透析クリニック
  • 独立系検査プロバイダー

第5章 北米市場

  • 概要
  • 米国市場
  • カナダ市場

第6章 欧州・中東・アフリカ (EMEA) 市場

  • 概要
  • ドイツ市場
  • フランス市場
  • イタリア市場
  • スペイン市場
  • 英国市場
  • スイス市場
  • 他のEMEA諸国
    • 中東
    • トルコ

第7章 アジア太平洋市場

  • 概要
  • 日本市場
  • 中国市場
  • インド市場
  • 韓国市場
  • オーストラリア市場
  • 他のアジア太平洋市場
    • シンガポール
    • インドネシア
    • フィリピン
    • 台湾

第8章 ラテンアメリカ市場

  • 概要
  • ブラジル市場
  • メキシコ市場
  • 他のラテンアメリカ市場
    • アルゼンチン
    • チリ
    • コロンビア
    • ペルー
    • ベネズエラ

第9章 主要な市場参入企業

  • 世界市場の概要
  • 米国企業の分析
  • QUEST DIAGNOSTICS, INC.
    • 企業概要
    • 業績概要
    • 昨今の企業買収・事業提携の動き
    • 主要製品/サービス
    • 新型コロナウイルス感染症 (COVID-19) の影響
  • LABORATORY CORPORATION OF AMERICA
  • SONIC HEALTHCARE LIMITED
  • SYNLAB INTERNATIONAL GMBH (SYNLAB BONDCO PLC)
  • EXACT SCIENCES CORP.
  • EUROFINS SCIENTIFIC SE
  • MIRACA HOLDINGS, INC.
  • BIOREFERENCE LABORATORIES - AN OPKO HEALTH SUBSIDIARY
  • UNILABS
  • SIEMENS HEALTHINEERS

第10章 市場動向・サマリー

  • 世界市場の概要
  • 地域別の概要
  • 人口増加
  • 高齢化人口
  • 病気の負担の増加
  • 発展途上国の経済成長
  • 先進国の経済の安定化
  • 価格圧力
  • 効率的な医療システムへの関心増大
  • ヘルスケアサービス需要の全体的な成長
  • 新型コロナウイルス感染症 (COVID-19)

付録I:CLIAに基づく認定機関

目次
Product Code: 21-027

“Clinical Laboratory Services Market, 6th Edition”, new from Kalorama Information, provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including:

  • North America (United States, Canada)
  • Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland)
  • Asia Pacific (Japan, China, India, South Korea, Australia)
  • Latin America (Brazil, Mexico)

The laboratory service market is also covered by specialty, including:

  • Essential and Routine Testing (clinical chemistry, hematology, coagulation, endocrinology)
  • Immunology and Microbiology Testing
  • Cytology and Histology Testing
  • Genetic Testing
  • Toxicology Testing (drugs of abuse)
  • COVID-19, as of 2020

A global market analysis by laboratory type is also displayed, including:

  • Independent and Reference Laboratories
  • Hospital-based Laboratories
  • Clinic-based Laboratories

Also included is a competitive analysis of leading clinical laboratory providers.

All market data pertains to the world market at the manufacturers' level. The base year for data is 2020. Historical data is provided for the years 2010 through 2019, with forecast data provided for 2020 through 2025. Compound annual growth rates (CAGRs) are provided for the 2020-2025 periods for each segment covered. A U.S. competitive analysis is provided for the year 2020, based on performance through third quarter reports. The forecasted market analysis through 2025 was largely based on demographic trends, disease trends, new developments, company performance trends, merger and acquisitions, and national expansion.

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • INDUSTRY AT A GLANCE
  • SCOPE AND METHODOLOGY
  • GLOBAL MARKET OVERVIEW
    • Table 1-1: Global Clinical Laboratory Market Analysis, 2010-2025 (in millions of dollars at the manufacturer's level)
    • Figure 1-1: Global Clinical Laboratory Market Analysis: 2010-2025
  • Market Conclusions
    • The United States and China are the most attractive clinical laboratory markets for growth and new opportunities
    • The U.S. is the largest market for clinical laboratory revenues
    • Emerging markets are becoming increasingly competitive
    • Specialty testing services will be primary drivers for the global market
    • Pricing, and to a lesser extent test exclusion, will likely impact industry performance and participation in future years
    • Diversifying geographic participation and payer groups are a growing strategy to remain competitive
    • Newer technologies, molecular testing services, shifting test volume to less conventional areas
    • COVID-19 Future Impact
  • KEY ISSUES AND TRENDS AFFECTING THE MARKET
  • LEADING MARKET PARTICIPANTS

CHAPTER TWO: INDUSTRY OVERVIEW

  • CLINICAL LABORATORY DESCRIPTION
    • Figure 2-1: Hospital Length of Stay in Days (2018-2019 Average)
  • NUMBER OF LABORATORY HEALTH WORKERS BY COUNTRY
    • Figure 2-2: Laboratory Health Workers by Country, 2010-2019 Average
  • THE LARGEST CLINICAL LABORATORY MARKET: THE UNITED STATES
  • Structure and Regulation in the U.S.
    • Certificate of Waiver
      • Table 2-1: Selected CLIA Waived Laboratory Tests
    • Certificate of Provider-Performed Microscopy Procedures (PPMP)
      • Table 2-2: Provider-Performed Microscopy Procedures
    • Certificate of Compliance and Certificate of Accreditation
      • Figure 2-3: Clinical Laboratory Certificate of Accreditation Issued by Organization (non-exempt laboratories only), March 2020
      • Table 2-3: Clinical Laboratory Certificates Issued by Type (non-exempt laboratories only), as of March 2020
      • Figure 2-4: Laboratory Certificate Trends by Application Type, July 2010- March 2020
    • States Exempt from Federal Clinical Laboratory Improvements Amendments (CLIA) of 1988
      • Table 2-4: CLIA Exempt States, Number of Laboratories, as of March 2020
  • LABORATORY DEVELOPED TEST REGULATIONS
    • Directive 98/79/EC
    • Health Canada Changes and Forecasted Action
  • PAYERS AND REIMBURSEMENT
  • Laboratory Service Payer Types
    • Table 2-5: U.S. Clinical Laboratory Revenues by Client and Payer Type (%), 2020
    • Figure 2-5: Clinical Laboratory Revenues by Client and Payer Type, 2020 Estimates
  • Trends in Medicare Reimbursement
    • Figure 2-6: Medicare Reimbursement Trends, Average Reimbursement for Clinical Laboratory Services, 2009 through 2020
  • Health Care Reform
  • Protecting Access to Medicare Act (PAMA) of 2014
    • Table 2-6: Proposed Clinical Diagnostic Laboratory Test Rates, 2020-2023
    • Impact of CARES Act on PAMA
  • Advanced Laboratory Tests (ADLT)
    • Table 2-7: List of Approved ADLTs, March 2021
  • Bundled Insurance Payments for ESRD Patients
    • Table 2-8: Laboratory Tests Subject to ESRD Consolidated Billing (CY 2019)
  • Commercial Insurance Providers
    • Table 2-9: National Commercial Insurance Provider List, 2020
    • Figure 2-7: National Commercial Insurance Providers by Membership and Total Revenues, 2020
  • TRANSPARENCY IN PRICING
    • Figure 2-8: Revenue and Test Volume Trends, Quest Diagnostics
  • DIRECT-TO-CONSUMER TESTING
    • Table 2-10: Select DTC Tests and Prices by Laboratory Service Provider (Quest Direct and Pixel LabCorp) 2019 (in US $)
  • DTC in Genetic Testing
  • EXPANDING CANCER TEST UTILIZATION AND TECHNOLOGIES
  • LabCorp and QIAGEN Launch new Companion Diagnostic for Metastatic Breast Cancer Therapy
  • Foundation Medicine signs $111M contract with Department of Veterans Affairs
  • Quest Diagnostics Attention to Oncology
  • THE ROLE OF INFORMATION TECHNOLOGY
    • Table 2-11: Selected Laboratory Information Management System Providers, 2020 Vendor List
  • INDUSTRY DRIVERS
  • Global Demographics
    • Table 2-12: The Global Population, 1980-2050
    • Figure 2-9: The Global Population, 1980-2050 (in millions)
    • Regional Population Overview
      • Table 2-13: World Population by Major Geographic Region, 2010 - 2050
      • Figure 2-10: World Population by Major Geographic Region, 2010-2050
    • Aging Populations
      • Table 2-14: Global Population Trends Age 65+, 2000-2050
      • Figure 2-11: Global Population Trends Age 65+, 2000-2050 (Millions)
  • Chronic Diseases and Conditions
    • Figure 2-12: Global Prevalence of Disease, 2000, 2015 and Projected 2030
    • Figure 2-13: Global Causes of Death, 2000, 2010 and 2016
    • Figure 2-14: Change in Mortality Over 2000-2016 Period
  • Economic Performance
    • Health Expenditures
      • Figure 2-15: Global Health Spending as a Percentage of GDP, by Country, 2019 estimates (%)

CHAPTER THREE: TESTING SERVICES BY SPECIALTY

  • TEST AND SERVICES OVERVIEW
    • Figure 3-1: Global Clinical Laboratory Market Analysis: Service Revenue Trend, 2010-2025 ($millions)
    • Table 3-1: Global Clinical Laboratory Market Analysis by Test Segment (Clinical Chemistry: Routine & Essential; Immunology & Microbiology; Cytology & Histology; Genetic; Toxicology; COVID-19), 2010-2025 (in millions of dollars at the manufacturers' level)
    • Figure 3-2: Global Clinical Laboratory Market Analysis: Segment Growth Forecast, CAGR 2020-2025 (excluding COVID-19)
    • Figure 3-3: Global Clinical Laboratory Market Analysis by Testing Service, Distribution of Revenues 2020 (%)
  • CLINICAL CHEMISTRY - ROUTINE AND ESSENTIAL TESTING
    • Figure 3-4: Global Clinical Laboratory Market Analysis: Clinical Chemistry: Routine & Essential Testing Service Market Trend, 2010-2025
    • Table 3-2: Market Overview - Routine and Essential Testing, 2020
  • Routine Clinical Chemistry
  • Cholesterol Level Testing
    • Table 3-3: High Cholesterol Risk Categories
    • Table 3-4: Raised or At-Risk Total Cholesterol (> = 190 mg/dL) age standardized estimates, 2008 data
  • Urinalysis
    • Table 3-5: Normal Reference Levels in a Medical Urinalysis
  • Hematology
    • Blood Cell Count
      • Table 3-6: Laboratory Reference Parameters for CBC
  • Coagulation
  • Endocrinology
    • Thyroid Function Tests
    • Pregnancy Testing
      • Table 3-7: HCG Levels in Pregnant Women by Days Past Ovulation
  • IMMUNOLOGY AND MICROBIOLOGY
    • Figure 3-5: Global Clinical Laboratory Market Analysis: Immunology & Microbiology Testing Service Market Trend, 2010-2025
    • Table 3-8: Market Overview - Immunology & Microbiology Testing, 2020
  • Allergy and Food Intolerance
  • Tumor Markers
  • Cardiac Markers
  • HIV Testing
    • Table 3-9: Number of Reported HIV Tests Performed by Country, 2018
    • Figure 3-6: Number of HIV Testing/Counseling Facilities per 100,000 Adult Populations and HIV Positive Population per 1,000 by Select Country (2017)
  • CYTOLOGY AND HISTOLOGY TESTING
    • Figure 3-7: Global Clinical Laboratory Market Analysis: Cytology & Histology Testing Service Market Trend, 2010-2025
    • Table 3-10: Market Overview - Cytology & Histology Testing, 2020
    • Pap Test
    • Figure 3-8: Percent of Females Aged 20-69 Screened for Cervical Cancer (all screening methods), by Select Country 2016/2017 Estimates
  • GENETIC TESTING
    • Figure 3-9: Global Clinical Laboratory Market Analysis: Genetic Testing Service Market Trend, 2010-2025
    • Table 3-11: Market Overview - Genetic Testing, 2020
  • TOXICOLOGY TESTING
    • Figure 3-10: Global Clinical Laboratory Market Analysis: Toxicology Testing Service Market Trend, 2010-2025
    • Table 3-12: Substance Detection Periods by Test Method
  • COVID-19 VIRUS TESTING
    • Figure 3-11: Global Distribution of COVID-19 Test Services: Volume, 2020
    • Figure 3-12: Factors Affecting COVID-19 Clinical Testing Market, 2021 and Beyond

CHAPTER FOUR: GLOBAL CLINICAL LABORATORY MARKET BY PROVIDER GROUP

  • CLINICAL LABORATORY MARKET: PROVIDER OVERVIEW
    • Table 4-1: Global Clinical Laboratory Market Analysis by Provider Segment, 2020, 2025 (Hospitals, Physician Offices/Outpatient Clinics, Independent)
    • Figure 4-1: Global Clinical Laboratory Market Analysis: Provider Segment Growth Forecast, CAGR 2020-2025
    • Figure 4-2: Global Clinical Laboratory Market Analysis by Provider Group, Distribution of Revenues 2020 (%)
  • HOSPITALS AND ACUTE CARE PROVIDERS
    • Figure 4-3: COVID-19 Impact on Hospital-based Laboratory Testing Markets, $millions
    • Table 4-2: Global Clinical Laboratory Market Analysis: Hospital and Acute Care Laboratory Testing Market 2020 and 2025 (U.S./International Estimates)
    • Figure 4-4: Hospital Beds per 1,000 Population by Country, 2020
  • PHYSICIANS AND OUTPATIENT CARE PROVIDERS
    • Figure 4-5: COVID-19 Impact on Physician-based Laboratory Testing Markets, $millions
    • Table 4-3: Global Clinical Laboratory Market Analysis: Physician and Outpatient Care Laboratory Testing Market 2020 and 2025 (U.S./International Estimates)
  • Physician Offices
    • Figure 4-6: Medical Doctors per 1,000 Population by Country, 2019/2020
  • Global Nursing Establishments and Assisted Living Facilities
  • Global Dialysis Clinics
  • INDEPENDENT LABORATORY PROVIDERS
    • Figure 4-7: COVID-19 Impact on Independent Laboratory Testing Markets, $millions
    • Table 4-4: Revenues for Selected U.S.-based Reference Labs 2015-2020 ($million, estimated)
    • Table 4-5: Estimated Clinical Test Volume by Select Independent Laboratory, 2020 (millions of units)
    • Table 4-6: Estimated COVID-19 Test Volume by Select Independent Laboratory, 2020 (millions of units)
    • Table 4-7: Global Clinical Laboratory Market Analysis: Independent Laboratory Testing Market 2020 and 2025 (U.S./International Estimates)

CHAPTER FIVE: NORTH AMERICA MARKET

  • OVERVIEW
    • Table 5-1: North America Market Value by Country, 2020 (in millions of dollars at the manufacturers' level)
  • UNITED STATES
    • Table 5-2: The United States Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
    • Figure 5-1: The United States Clinical Laboratory Service Market, Performance 2010-2025 ($millions)
  • U.S. Market by Test Type
    • Table 5-3: The United States Clinical Laboratory Service Market by Testing Services, Estimates and Forecast 2020 and 2025 ($millions)
    • Figure 5-2: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues by Type, 2020
    • Figure 5-3: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues Over Time by Type, 2010-2025 ($millions)
  • U.S. Market by Laboratory Provider Type
    • Table 5-4: The United States Clinical Laboratory Service Market by Laboratory Type, Estimates and Forecast 2020 and 2025 ($millions)
    • Figure 5-4: U.S. Clinical Laboratory Market Share by Laboratory Type, 2020
    • Figure 5-5: U.S. Clinical Laboratory Market Analysis: Testing Service Revenues Over Time by Laboratory Type, 2010-2025 ($millions)
  • U.S. Clinical Laboratory Industry Structure
    • Figure 5-6: Growth in Clinical Laboratories, 1997-2020
    • CLIA Laboratory Registration, Laboratories by Type
      • Figure 5-7: U.S. CLIA Clinical Laboratory Registration by Primary Laboratory Type: March 2020
      • Table 5-5: CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) March 2020
      • Figure 5-8: Growth Trends in CLIA Registered Laboratories by Type of Facility (Exempt/Non-Exempt Combined) June 2011 and March 2020
      • Figure 5-9: Change in CLIA Registered Laboratories by Type of Facility, Highest and Lowest Growth Segments, % Change, Compounded Annually 2011-2020
  • Independent Clinical Laboratories
    • Table 5-6: Leading U.S. Independent Laboratory Groups, as of March 2020
    • Figure 5-10: Leading U.S. Independent Laboratory Groups, Distribution of Centers, as of March 2020
    • Growth in Independent Clinical Laboratories
      • Figure 5-11: Growth in U.S. Independent Laboratory Facilities, June 2011 through March 2020
  • Hospital-based Laboratories
    • U.S. Hospital Data
      • Figure 5-12: Number of Hospitals in the U.S., 1975-2019
      • Table 5-7: U.S. Hospital Types
      • Table 5-8: AHA Statistics - U.S. Registered Hospitals by Type, 2010 through 2019
      • Table 5-9: AHA Statistics for U.S. Hospitals, 2012-2019
    • U.S. Hospital Stay Stats
      • Figure 5-13: U.S. Hospital Length of Stay, Average by Broad Age Group, 2016
    • Growth in Hospital Clinical Laboratories
      • Figure 5-14: Growth in U.S. Hospital Laboratory Locations, June 2011 through March 2020
  • Physician-office and Clinic Laboratories
    • Number of U.S. Physicians
      • Figure 5-15: Number of Physician Offices, United States, 2000-2017, Estimated 2018
    • Growth in Clinical Laboratories in the Physician Office
      • Figure 5-16: Growth in U.S. Physician Office Laboratory Locations, June 2011 through March 2020
  • Nursing Facility and Home Health
    • U.S. Nursing Home Establishments
      • Figure 5-17: Number of Nursing Homes (United States), 2000-2017, Estimated 2018
    • U.S. Home Health Facilities
    • Growth in Clinical Laboratories in the Nursing Facility and Home Health Segment
      • Figure 5-18: Growth in U.S. Nursing Facility/Home Health Laboratory Locations, June 2011 through March 2020
  • Pharmacy-based Laboratories
    • Growth in Pharmacy-Based Clinical Laboratories
      • Figure 5-19: Growth in U.S. Pharmacy-Based Laboratories, mid-2011 through March 2020
  • Dialysis Clinics
    • Growth in U.S. Dialysis Clinics and Affiliated Laboratories
      • Figure 5-20: Growth in U.S. Dialysis Clinic-based Laboratories, mid-2011 through March 2020
  • CANADA
    • Table 5-10: Canada Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
    • Figure 5-21: Canada Clinical Laboratory Service Market, Performance 2010-2025 ($millions)

CHAPTER SIX: EMEA MARKET

  • OVERVIEW
    • Table 6-1: EMEA Market Value by Country, 2020 (in millions of dollars at the manufacturers' level)
    • Figure 6-1: EMEA Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2020-2025
  • GERMANY
    • Table 6-2: Germany Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
    • Figure 6-2: Leading Laboratory Service Suppliers by Estimated Distribution of Revenues, Germany, 2020
  • FRANCE
    • Table 6-3: France Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • ITALY
    • Table 6-4: Italy Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • SPAIN
    • Table 6-5: Spain Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • UNITED KINGDOM
    • Table 6-6: United Kingdom Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • SWITZERLAND
    • Table 6-7: Switzerland Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • REST OF EMEA
    • Middle East
    • Turkey

CHAPTER SEVEN: ASIA PACIFIC MARKET

  • OVERVIEW
    • Table 7-1: Asia Pacific Clinical Laboratory Service Market Value by Country, 2020 (in millions of dollars at the manufacturers' level)
    • Figure 7-1: Asia Pacific Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2020-2025
  • JAPAN
    • Table 7-2: Japan Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • Japan Clinical Laboratory Industry Structure
    • Figure 7-2: Japan Clinical Laboratory Industry by Type, 2020
    • Figure 7-3: Japan Clinical Laboratory Industry by Test Classification, 2020
    • Figure 7-4: Japan Clinical Laboratory Industry, Number of Laboratories by Prefecture, 2020
  • CHINA
    • Table 7-3: China Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • China Clinical Laboratory Industry Structure
    • Figure 7-5: China Clinical Laboratory Industry by Type, 2020
  • INDIA
    • Table 7-4: India Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • SOUTH KOREA
    • Table 7-5: South Korea Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • AUSTRALIA
    • Table 7-6: Australia Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • REST OF ASIA PACIFIC
    • Singapore
    • Indonesia
    • Philippines
    • Taiwan

CHAPTER EIGHT: LATIN AMERICA MARKET

  • OVERVIEW
    • Table 8-1: Latin America Market Value by Country, 2020 (in millions of dollars at the manufacturers' level)
    • Figure 8-1: Latin America Clinical Laboratory Service Market, Growth Projections by Country, CAGR 2020-2025
  • BRAZIL
    • Table 8-2: Brazil Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • MEXICO
    • Table 8-3: Mexico Clinical Laboratory Service Market, Estimates and Forecast 2020 and 2025 ($millions)
  • REST OF LATIN AMERICA
    • Argentina
    • Chile
      • Table 8-4: Estimated Clinical Labs in Chile (Average Tests/Year, Number of Labs, Private Sector, Public Sector) - 2019
    • Colombia
      • Table 8-5: Classification of Laboratories by Test Complexity
    • Peru
    • Venezuela

CHAPTER NINE: LEADING MARKET PARTICIPANTS

  • GLOBAL COMPETITOR SUMMARY
    • Figure 9-1: Top 10 Market Participants, Global Service Revenues, Estimated 2019 and 2020 ($millions)
    • Figure 9-2: Market Contribution by Clinical Laboratory Service Providers, 2020
  • U.S. COMPETITIVE ANALYSIS
    • Table 9-1: Estimated U.S. Laboratory Service Revenues and Market Share of Leading Clinical Laboratory Providers, 2020
    • Figure 9-2: Estimated U.S. Laboratory Services, Market Share of Leading Clinical Laboratory Providers, 2020

1: QUEST DIAGNOSTICS, INC.

  • Company Overview
    • Table 9-3: Quest Diagnostics Corporate Details
  • Performance Review
    • Figure 9-3: Quest Diagnostics Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

2: LABORATORY CORPORATION OF AMERICA

  • Company Overview
    • Table 9-4: Laboratory Corporation of America Corporate Details
  • Performance Review
    • Figure 9-4: Laboratory Corporation of America Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

3: SONIC HEALTHCARE LIMITED

  • Company Overview
    • Table 9-5: Sonic Healthcare Corporate Details
  • Performance Review
    • Figure 9-5: Sonic Healthcare Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

4: SYNLAB INTERNATIONAL GMBH (SYNLAB BONDCO PLC)

  • Company Overview
    • Table 9-6: SYNLAB Corporate Details
  • Performance Review
    • Figure 9-6: SYNLAB Revenue Summary, 2016-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

5: EXACT SCIENCES CORP.

  • Company Overview
    • Table 9-7: Exact Sciences Corporate Details
  • Performance Review
    • Figure 9-7: Exact Sciences Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

6: EUROFINS SCIENTIFIC SE

  • Company Overview
    • Table 9-8: Eurofins Scientific Corporate Details
  • Performance Review
    • Figure 9-8: Eurofins Scientific Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

7: MIRACA HOLDINGS, INC.

  • Company Overview
    • Table 9-9: Miraca - H.U. Group Holdings, Inc. Corporate Details
  • Performance Review
    • Figure 9-9: Miraca Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

8: BIOREFERENCE LABORATORIES - AN OPKO HEALTH SUBSIDIARY

  • Company Overview
    • Table 9-10: BioReference Laboratories Corporate Details
  • Key Acquisitions, Alliances, and Partnerships
  • Performance Review
    • Figure 9-10: BioReference Laboratories Revenue Summary, 2010-2020 ($millions)
  • Products and Services
    • COVID-19 Events and Impact

9: UNILABS

  • Company Overview
    • Table 9-11: Unilabs Corporate Details
  • Performance Review
  • Products and Services
    • COVID-19 Events and Impact

10: SIEMENS HEALTHINEERS

  • Company Overview
    • Table 9-12: Siemens Healthineers Corporate Details
  • Performance Review
    • Figure 9-11: Siemens Healthineers' Revenue Summary, 2010-2020 ($millions)
  • Key Acquisitions, Alliances, and Partnerships
  • Products and Services
    • COVID-19 Events and Impact

CHAPTER TEN: MARKET TRENDS AND SUMMARY

  • GLOBAL MARKET OVERVIEW
    • Table 10-1: Global Clinical Laboratory Market Analysis, 2010-2025 (in millions of dollars at the manufacturer's level)
    • Figure 10-1: Global Clinical Laboratory Market Analysis: 2010-2025
  • REGIONAL OVERVIEW
    • Table 10-2: Global Clinical Laboratory Service Market Analysis, Revenues by Region, 2020
    • Figure 10-2: Global Clinical Laboratory Market Analysis, Revenues by Region, 2020
    • Figure 10-3: Global Clinical Laboratory Market Analysis: Regional Growth Forecast, CAGR 2020-2025
    • Figure 10-4: Estimated COVID-19 Market Performance by Region, 2020
  • Population growth
  • Aging populations
  • Increasing disease burden
  • Economic growth in developing regions
  • Stabilizing economies in developed regions
  • Pricing pressures
  • Focusing on Efficient health systems
  • Overall growth in demand for health care services
  • COVID-19

APPENDIX I: ACCREDITATION ORGANIZATIONS UNDER CLIA

  • AABB
  • AMERICAN ASSOCIATION FOR LABORATORY ACCREDITATION
  • ACCREDITATION ASSOCIATION FOR HOSPITALS AND HEALTH SYSTEMS/HEALTHCARE FACILITIES ACCREDITATION PROGRAM (AAHHS/HFAP) (FORMERLY KNOWN AS THE AMERICAN OSTEOPATHIC ASSOCIATION/HEALTHCARE FACILITIES ACCREDITATION PROGRAM (AOA/HFAP))
  • AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS
  • COLA
  • COLLEGE OF AMERICAN PATHOLOGISTS